
Sign up to save your podcasts
Or


Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.
(00:00) - intro
(00:54) - Daphne’s journey
(09:18) - AI and biology discovery
(10:59) - insitro vs. traditional pharma
(20:04) - phenotyping patients
(26:01) - early mistakes
(29:51) - the future of data
(35:33) - partnering with larger pharma companies
(38:17) - impact of LLMs on biopharma
(44:04) - over-hyped/under-hyped
With your co-hosts:
@jasoncwarner - Former CTO GitHub, VP Eng Heroku & Canonical
@ericabrescia - Former COO Github, Founder Bitnami (acq’d by VMWare)
@patrickachase - Partner at Redpoint, Former ML Engineer LinkedIn
@jacobeffron - Partner at Redpoint, Former PM Flatiron Health
By by Redpoint Ventures4.9
5151 ratings
Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.
(00:00) - intro
(00:54) - Daphne’s journey
(09:18) - AI and biology discovery
(10:59) - insitro vs. traditional pharma
(20:04) - phenotyping patients
(26:01) - early mistakes
(29:51) - the future of data
(35:33) - partnering with larger pharma companies
(38:17) - impact of LLMs on biopharma
(44:04) - over-hyped/under-hyped
With your co-hosts:
@jasoncwarner - Former CTO GitHub, VP Eng Heroku & Canonical
@ericabrescia - Former COO Github, Founder Bitnami (acq’d by VMWare)
@patrickachase - Partner at Redpoint, Former ML Engineer LinkedIn
@jacobeffron - Partner at Redpoint, Former PM Flatiron Health

548 Listeners

1,096 Listeners

2,347 Listeners

235 Listeners

10,216 Listeners

100 Listeners

564 Listeners

512 Listeners

144 Listeners

101 Listeners

459 Listeners

33 Listeners

137 Listeners

41 Listeners

59 Listeners